Selective Antagonists of the Bronchiolar Epithelial NF-κB-Bromodomain-Containing Protein 4 Pathway in Viral-Induced Airway Inflammation

Bing Tian, Zhiqing Liu, Jun Yang, Hong Sun, Yingxin Zhao, Maki Wakamiya, Haiying Chen, Erik Rytting, Jia Zhou, Allan R. Brasier

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The mechanisms by which the mammalian airway detects invading viral pathogens to trigger protective innate neutrophilic inflammation are incompletely understood. We observe that innate activation of nuclear factor κB (NF-κB)/RelA transcription factor indirectly activates atypical BRD4 histone acetyltransferase (HAT) activity, RNA polymerase II (Pol II) phosphorylation, and secretion of neutrophilic chemokines. To study this pathway in vivo, we developed a conditional knockout of RelA in distal airway epithelial cells; these animals have reduced mucosal BRD4/Pol II activation and neutrophilic inflammation to viral patterns. To further understand the role of BRD4 in vivo, two potent, highly selective small-molecule BRD4 inhibitors were developed. These well-tolerated inhibitors disrupt the BRD4 complex with Pol II and histones, completely blocking inducible epithelial chemokine production and neutrophilia. We conclude that RelA-BRD4 signaling in distal tracheobronchiolar epithelial cells mediates acute inflammation in response to luminal viral patterns. These potent BRD4 antagonists are versatile pharmacological tools for investigating BRD4 functions in vivo. Tian et al. demonstrate that viral patterns activate RelA to complex with BRD4 and indirectly activate its enzymatic activity in distal trachea-bronchiolar cells to induce acute neutrophilic airway inflammation. Two highly selective, small-molecule inhibitors of BRD4 were developed. These disrupt BRD4 complex formation, HAT activity, and neutrophilia in vivo.

Original languageEnglish (US)
JournalCell Reports
DOIs
StateAccepted/In press - Jan 1 2018
Externally publishedYes

Fingerprint

Histone Acetyltransferases
Inflammation
Chemokines
Transcription Factor RelA
Chemical activation
Phosphorylation
Proteins
Molecules
RNA Polymerase II
Epithelial Cells
Pathogens
Histones
Animals
Trachea
Pharmacology

Keywords

  • airway inflammation
  • bromodomain containing protein 4
  • histone acetyltransferase activity
  • innate immune response
  • NF-κB

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Selective Antagonists of the Bronchiolar Epithelial NF-κB-Bromodomain-Containing Protein 4 Pathway in Viral-Induced Airway Inflammation. / Tian, Bing; Liu, Zhiqing; Yang, Jun; Sun, Hong; Zhao, Yingxin; Wakamiya, Maki; Chen, Haiying; Rytting, Erik; Zhou, Jia; Brasier, Allan R.

In: Cell Reports, 01.01.2018.

Research output: Contribution to journalArticle

@article{d106d2e71bbb499180ef0c6fca8df119,
title = "Selective Antagonists of the Bronchiolar Epithelial NF-κB-Bromodomain-Containing Protein 4 Pathway in Viral-Induced Airway Inflammation",
abstract = "The mechanisms by which the mammalian airway detects invading viral pathogens to trigger protective innate neutrophilic inflammation are incompletely understood. We observe that innate activation of nuclear factor κB (NF-κB)/RelA transcription factor indirectly activates atypical BRD4 histone acetyltransferase (HAT) activity, RNA polymerase II (Pol II) phosphorylation, and secretion of neutrophilic chemokines. To study this pathway in vivo, we developed a conditional knockout of RelA in distal airway epithelial cells; these animals have reduced mucosal BRD4/Pol II activation and neutrophilic inflammation to viral patterns. To further understand the role of BRD4 in vivo, two potent, highly selective small-molecule BRD4 inhibitors were developed. These well-tolerated inhibitors disrupt the BRD4 complex with Pol II and histones, completely blocking inducible epithelial chemokine production and neutrophilia. We conclude that RelA-BRD4 signaling in distal tracheobronchiolar epithelial cells mediates acute inflammation in response to luminal viral patterns. These potent BRD4 antagonists are versatile pharmacological tools for investigating BRD4 functions in vivo. Tian et al. demonstrate that viral patterns activate RelA to complex with BRD4 and indirectly activate its enzymatic activity in distal trachea-bronchiolar cells to induce acute neutrophilic airway inflammation. Two highly selective, small-molecule inhibitors of BRD4 were developed. These disrupt BRD4 complex formation, HAT activity, and neutrophilia in vivo.",
keywords = "airway inflammation, bromodomain containing protein 4, histone acetyltransferase activity, innate immune response, NF-κB",
author = "Bing Tian and Zhiqing Liu and Jun Yang and Hong Sun and Yingxin Zhao and Maki Wakamiya and Haiying Chen and Erik Rytting and Jia Zhou and Brasier, {Allan R.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.celrep.2018.03.106",
language = "English (US)",
journal = "Cell Reports",
issn = "2211-1247",
publisher = "Cell Press",

}

TY - JOUR

T1 - Selective Antagonists of the Bronchiolar Epithelial NF-κB-Bromodomain-Containing Protein 4 Pathway in Viral-Induced Airway Inflammation

AU - Tian, Bing

AU - Liu, Zhiqing

AU - Yang, Jun

AU - Sun, Hong

AU - Zhao, Yingxin

AU - Wakamiya, Maki

AU - Chen, Haiying

AU - Rytting, Erik

AU - Zhou, Jia

AU - Brasier, Allan R.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The mechanisms by which the mammalian airway detects invading viral pathogens to trigger protective innate neutrophilic inflammation are incompletely understood. We observe that innate activation of nuclear factor κB (NF-κB)/RelA transcription factor indirectly activates atypical BRD4 histone acetyltransferase (HAT) activity, RNA polymerase II (Pol II) phosphorylation, and secretion of neutrophilic chemokines. To study this pathway in vivo, we developed a conditional knockout of RelA in distal airway epithelial cells; these animals have reduced mucosal BRD4/Pol II activation and neutrophilic inflammation to viral patterns. To further understand the role of BRD4 in vivo, two potent, highly selective small-molecule BRD4 inhibitors were developed. These well-tolerated inhibitors disrupt the BRD4 complex with Pol II and histones, completely blocking inducible epithelial chemokine production and neutrophilia. We conclude that RelA-BRD4 signaling in distal tracheobronchiolar epithelial cells mediates acute inflammation in response to luminal viral patterns. These potent BRD4 antagonists are versatile pharmacological tools for investigating BRD4 functions in vivo. Tian et al. demonstrate that viral patterns activate RelA to complex with BRD4 and indirectly activate its enzymatic activity in distal trachea-bronchiolar cells to induce acute neutrophilic airway inflammation. Two highly selective, small-molecule inhibitors of BRD4 were developed. These disrupt BRD4 complex formation, HAT activity, and neutrophilia in vivo.

AB - The mechanisms by which the mammalian airway detects invading viral pathogens to trigger protective innate neutrophilic inflammation are incompletely understood. We observe that innate activation of nuclear factor κB (NF-κB)/RelA transcription factor indirectly activates atypical BRD4 histone acetyltransferase (HAT) activity, RNA polymerase II (Pol II) phosphorylation, and secretion of neutrophilic chemokines. To study this pathway in vivo, we developed a conditional knockout of RelA in distal airway epithelial cells; these animals have reduced mucosal BRD4/Pol II activation and neutrophilic inflammation to viral patterns. To further understand the role of BRD4 in vivo, two potent, highly selective small-molecule BRD4 inhibitors were developed. These well-tolerated inhibitors disrupt the BRD4 complex with Pol II and histones, completely blocking inducible epithelial chemokine production and neutrophilia. We conclude that RelA-BRD4 signaling in distal tracheobronchiolar epithelial cells mediates acute inflammation in response to luminal viral patterns. These potent BRD4 antagonists are versatile pharmacological tools for investigating BRD4 functions in vivo. Tian et al. demonstrate that viral patterns activate RelA to complex with BRD4 and indirectly activate its enzymatic activity in distal trachea-bronchiolar cells to induce acute neutrophilic airway inflammation. Two highly selective, small-molecule inhibitors of BRD4 were developed. These disrupt BRD4 complex formation, HAT activity, and neutrophilia in vivo.

KW - airway inflammation

KW - bromodomain containing protein 4

KW - histone acetyltransferase activity

KW - innate immune response

KW - NF-κB

UR - http://www.scopus.com/inward/record.url?scp=85045064712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045064712&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2018.03.106

DO - 10.1016/j.celrep.2018.03.106

M3 - Article

JO - Cell Reports

JF - Cell Reports

SN - 2211-1247

ER -